Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
RBA vs REZI vs JCI vs KAR vs HON
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Construction
Auto - Dealerships
Conglomerates
RBA vs REZI vs JCI vs KAR vs HON — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Security & Protection Services | Construction | Auto - Dealerships | Conglomerates |
| Market Cap | $19.27B | $6.04B | $85.23B | $2.91B | $136.91B |
| Revenue (TTM) | $4.74B | $7.47B | $24.43B | $1.93B | $36.76B |
| Net Income (TTM) | $452M | $-527M | $3.53B | $178M | $4.10B |
| Gross Margin | 33.4% | 29.4% | 36.6% | 46.2% | 36.9% |
| Operating Margin | 18.6% | 8.1% | 13.6% | 10.2% | 14.9% |
| Forward P/E | 23.7x | 13.1x | 29.4x | 19.3x | 20.5x |
| Total Debt | $5.50B | $3.17B | $11.19B | $1.42B | $34.58B |
| Cash & Equiv. | $694M | $661M | $379M | $142M | $12.49B |
RBA vs REZI vs JCI vs KAR vs HON — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| RB Global, Inc. (RBA) | 100 | 239.0 | +139.0% |
| Resideo Technologie… (REZI) | 100 | 570.4 | +470.4% |
| Johnson Controls In… (JCI) | 100 | 443.3 | +343.3% |
| OPENLANE, Inc. (KAR) | 100 | 198.7 | +98.7% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RBA vs REZI vs JCI vs KAR vs HON
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RBA ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 9.0%, EPS growth 3.5%, 3Y rev CAGR 39.1%
- Lower volatility, beta 0.68, Low D/E 90.9%, current ratio 1.10x
- Beta 0.68 vs REZI's 2.27, lower leverage
REZI carries the broadest edge in this set and is the clearest fit for growth and value.
- 10.5% revenue growth vs JCI's 2.8%
- Lower P/E (13.1x vs 20.5x)
- +111.6% vs RBA's +2.3%
JCI is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.
- 343.3% 10Y total return vs RBA's 270.4%
- PEG 1.15 vs HON's 11.18
- 14.5% margin vs REZI's -7.1%
- 9.0% ROA vs REZI's -6.2%, ROIC 8.5% vs 9.0%
Among these 5 stocks, KAR doesn't own a clear edge in any measured category.
HON is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Beta 0.74, yield 2.1%, current ratio 1.32x
- 2.1% yield, 15-year raise streak, vs RBA's 1.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.5% revenue growth vs JCI's 2.8% | |
| Value | Lower P/E (13.1x vs 20.5x) | |
| Quality / Margins | 14.5% margin vs REZI's -7.1% | |
| Stability / Safety | Beta 0.68 vs REZI's 2.27, lower leverage | |
| Dividends | 2.1% yield, 15-year raise streak, vs RBA's 1.2% | |
| Momentum (1Y) | +111.6% vs RBA's +2.3% | |
| Efficiency (ROA) | 9.0% ROA vs REZI's -6.2%, ROIC 8.5% vs 9.0% |
RBA vs REZI vs JCI vs KAR vs HON — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RBA vs REZI vs JCI vs KAR vs HON — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REZI leads in 2 of 6 categories
JCI leads 1 • HON leads 1 • RBA leads 0 • KAR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — RBA and KAR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 19.0x KAR's $1.9B. JCI is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to REZI's -7.1%. On growth, RBA holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.7B | $7.5B | $24.4B | $1.9B | $36.8B |
| EBITDAEarnings before interest/tax | $1.4B | $802M | $3.9B | $288M | $6.5B |
| Net IncomeAfter-tax profit | $452M | -$527M | $3.5B | $178M | $4.1B |
| Free Cash FlowCash after capex | $754M | -$1.3B | $1.4B | $337M | $4.2B |
| Gross MarginGross profit ÷ Revenue | +33.4% | +29.4% | +36.6% | +46.2% | +36.9% |
| Operating MarginEBIT ÷ Revenue | +18.6% | +8.1% | +13.6% | +10.2% | +14.9% |
| Net MarginNet income ÷ Revenue | +9.5% | -7.1% | +14.5% | +9.2% | +11.2% |
| FCF MarginFCF ÷ Revenue | +15.9% | -16.8% | +5.7% | +17.4% | +11.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.4% | +2.0% | +8.2% | +0.5% | -6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +20.0% | +11.4% | +38.9% | +89.7% | -41.9% |
Valuation Metrics
REZI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 16.7x trailing earnings, KAR trades at a 68% valuation discount to JCI's 52.9x P/E. Adjusting for growth (PEG ratio), JCI offers better value at 2.06x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $19.3B | $6.0B | $85.2B | $2.9B | $136.9B |
| Enterprise ValueMkt cap + debt − cash | $24.1B | $8.5B | $96.0B | $4.2B | $159.0B |
| Trailing P/EPrice ÷ TTM EPS | 49.72x | -10.68x | 52.95x | 16.73x | 29.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.65x | 13.07x | 29.38x | 19.31x | 20.52x |
| PEG RatioP/E ÷ EPS growth rate | 8.02x | — | 2.06x | — | 15.99x |
| EV / EBITDAEnterprise value multiple | 16.27x | 10.65x | 26.01x | 14.55x | 19.99x |
| Price / SalesMarket cap ÷ Revenue | 4.12x | 0.81x | 3.61x | 1.51x | 3.66x |
| Price / BookPrice ÷ Book value/share | 3.19x | 2.06x | 7.03x | 1.93x | 9.00x |
| Price / FCFMarket cap ÷ FCF | 26.33x | — | 88.32x | 8.66x | 25.39x |
Profitability & Efficiency
JCI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JCI delivers a 24.9% return on equity — every $100 of shareholder capital generates $25 in annual profit, vs $-18 for REZI. JCI carries lower financial leverage with a 0.86x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), KAR scores 8/9 vs REZI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.5% | -18.1% | +24.9% | +11.6% | +23.1% |
| ROA (TTM)Return on assets | +3.7% | -6.2% | +9.0% | +3.8% | +5.3% |
| ROICReturn on invested capital | +6.0% | +9.0% | +8.5% | +6.9% | +12.6% |
| ROCEReturn on capital employed | +7.9% | +9.3% | +9.8% | +9.4% | +12.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 6 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.91x | 1.09x | 0.86x | 0.93x | 2.24x |
| Net DebtTotal debt minus cash | $4.8B | $2.5B | $10.8B | $1.3B | $22.1B |
| Cash & Equiv.Liquid assets | $694M | $661M | $379M | $142M | $12.5B |
| Total DebtShort + long-term debt | $5.5B | $3.2B | $11.2B | $1.4B | $34.6B |
| Interest CoverageEBIT ÷ Interest expense | 5.34x | -2.36x | 18.41x | 3.09x | 3.92x |
Total Returns (Dividends Reinvested)
REZI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JCI five years ago would be worth $22,286 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, REZI leads with a +111.6% total return vs RBA's +2.3%. The 3-year compound annual growth rate (CAGR) favors REZI at 34.9% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.4% | +14.5% | +14.2% | -6.1% | +10.9% |
| 1-Year ReturnPast 12 months | +2.3% | +111.6% | +56.9% | +43.1% | +2.8% |
| 3-Year ReturnCumulative with dividends | +86.9% | +145.5% | +127.9% | +82.3% | +16.2% |
| 5-Year ReturnCumulative with dividends | +63.9% | +33.0% | +122.9% | +61.6% | +3.3% |
| 10-Year ReturnCumulative with dividends | +270.4% | +38.9% | +343.3% | +99.2% | +135.1% |
| CAGR (3Y)Annualised 3-year return | +23.2% | +34.9% | +31.6% | +22.2% | +5.1% |
Risk & Volatility
Evenly matched — RBA and JCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
RBA is the less volatile stock with a 0.68 beta — it tends to amplify market swings less than REZI's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.5% from its 52-week high vs KAR's 86.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 2.27x | 0.97x | 0.98x | 0.74x |
| 52-Week HighHighest price in past year | $119.58 | $45.29 | $147.32 | $31.78 | $248.18 |
| 52-Week LowLowest price in past year | $93.58 | $18.88 | $87.77 | $19.02 | $186.76 |
| % of 52W HighCurrent price vs 52-week peak | +86.5% | +88.9% | +94.5% | +86.3% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 58.0 | 61.4 | 56.2 | 40.9 | 45.1 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 1.1M | 3.3M | 976K | 3.7M |
Analyst Outlook
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RBA as "Buy", REZI as "Buy", JCI as "Buy", KAR as "Buy", HON as "Buy". Consensus price targets imply 19.9% upside for RBA (target: $124) vs -0.9% for JCI (target: $138). For income investors, HON offers the higher dividend yield at 2.14% vs REZI's 0.58%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $124.00 | $40.00 | $138.00 | $32.00 | $243.83 |
| # AnalystsCovering analysts | 23 | 7 | 45 | 18 | 28 |
| Dividend YieldAnnual dividend ÷ price | +1.2% | +0.6% | +1.1% | +1.3% | +2.1% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 5 | 0 | 15 |
| Dividend / ShareAnnual DPS | $1.22 | $0.23 | $1.49 | $0.36 | $4.63 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +7.0% | +1.6% | +2.8% |
REZI leads in 2 of 6 categories (Valuation Metrics, Total Returns). JCI leads in 1 (Profitability & Efficiency). 2 tied.
RBA vs REZI vs JCI vs KAR vs HON: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RBA or REZI or JCI or KAR or HON a better buy right now?
For growth investors, Resideo Technologies, Inc.
(REZI) is the stronger pick with 10. 5% revenue growth year-over-year, versus 2. 8% for Johnson Controls International plc (JCI). OPENLANE, Inc. (KAR) offers the better valuation at 16. 7x trailing P/E (19. 3x forward), making it the more compelling value choice. Analysts rate RB Global, Inc. (RBA) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RBA or REZI or JCI or KAR or HON?
On trailing P/E, OPENLANE, Inc.
(KAR) is the cheapest at 16. 7x versus Johnson Controls International plc at 52. 9x. On forward P/E, Resideo Technologies, Inc. is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Johnson Controls International plc wins at 1. 15x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — RBA or REZI or JCI or KAR or HON?
Over the past 5 years, Johnson Controls International plc (JCI) delivered a total return of +122.
9%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: JCI returned +343. 3% versus REZI's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RBA or REZI or JCI or KAR or HON?
By beta (market sensitivity over 5 years), RB Global, Inc.
(RBA) is the lower-risk stock at 0. 68β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately 234% more volatile than RBA relative to the S&P 500. On balance sheet safety, Johnson Controls International plc (JCI) carries a lower debt/equity ratio of 86% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RBA or REZI or JCI or KAR or HON?
By revenue growth (latest reported year), Resideo Technologies, Inc.
(REZI) is pulling ahead at 10. 5% versus 2. 8% for Johnson Controls International plc (JCI). On earnings-per-share growth, the picture is similar: OPENLANE, Inc. grew EPS 264. 4% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, RBA leads at 39. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RBA or REZI or JCI or KAR or HON?
Johnson Controls International plc (JCI) is the more profitable company, earning 13.
9% net margin versus -7. 1% for Resideo Technologies, Inc. — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RBA leads at 17. 7% versus 8. 1% for REZI. At the gross margin level — before operating expenses — KAR leads at 46. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RBA or REZI or JCI or KAR or HON more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Johnson Controls International plc (JCI) is the more undervalued stock at a PEG of 1. 15x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Resideo Technologies, Inc. (REZI) trades at 13. 1x forward P/E versus 29. 4x for Johnson Controls International plc — 16. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RBA: 19. 9% to $124. 00.
08Which pays a better dividend — RBA or REZI or JCI or KAR or HON?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 6% for Resideo Technologies, Inc. (REZI).
09Is RBA or REZI or JCI or KAR or HON better for a retirement portfolio?
For long-horizon retirement investors, RB Global, Inc.
(RBA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 68), 1. 2% yield, +270. 4% 10Y return). Resideo Technologies, Inc. (REZI) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RBA: +270. 4%, REZI: +38. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RBA and REZI and JCI and KAR and HON?
These companies operate in different sectors (RBA (Industrials) and REZI (Industrials) and JCI (Industrials) and KAR (Consumer Cyclical) and HON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RBA is a mid-cap quality compounder stock; REZI is a small-cap quality compounder stock; JCI is a mid-cap quality compounder stock; KAR is a small-cap deep-value stock; HON is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.